Showing results (2311-2320 of 2,674) with videos related to

Sort By:
Pageof 268
BJU International|March 8, 2021
UpFrontPSMA: a randomized phase 2 study of sequential 177 Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol)Nattakorn Dhiantravan, Louise Emmett, Anthony M Joshua, et al.
Circulation Research|October 13, 2000
Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i)J D Kilts, M A Gerhardt, M D Richardson, et al.
Internal Medicine Journal|January 29, 2011
An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009S Lingaratnam, M A Slavin, L Mileshkin, et al.
Internal Medicine Journal|August 2, 2014
Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort studyB O'Carrigan, M Fournier, I N Olver, et al.
Annals of the American Thoracic Society|July 1, 2020
Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy ControlsBreAnna Kinghorn, Sharon McNamara, Alan Genatossio, et al.
The Journal of Surgical Research|July 14, 2014
Paraspinous muscle as a predictor of surgical outcomeLeah D Canvasser, Alyssa A Mazurek, David C Cron, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2013
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety updateCora N Sternberg, Robert E Hawkins, John Wagstaff, et al.
Cancer Immunity|February 23, 2005
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanomaAndrew M Scott, Zhanqi Liu, Carmel Murone, et al.
Pediatric Pulmonology|May 24, 2018
Reference equations for the interpretation of forced expiratory and plethysmographic measurements in infantsZihang Lu, Rachel E Foong, Krzysztof Kowalik, et al.
The Lancet. Psychiatry|July 3, 2017
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trialKaren E Anderson, David Stamler, Mat D Davis, et al.
Pageof 268